Gs Investments, Inc. Biogen Inc. Transaction History

Gs Investments, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 07, 2020	SELL	$268.85 - $341.04 $134,425 - $170,520	-500 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$220.06 - $304.07 $110,030 - $152,035	500 New	500 $145 Million
Q3 2018 Nov 06, 2018	SELL	$293.51 - $383.83 $146,755 - $191,915	-500 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$257.52 - $306.91 $128,759 - $153,455	500 New	500 $145 Million
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $130,065 - $183,955	-500 Closed	0 $0
Q2 2017 Aug 29, 2017	BUY	N/A	500	500 $136 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Gs Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Gs Investments, Inc. with notifications on news.